| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/30/2026 | ±3.6% | +8.0% | under-priced |
| 11/04/2025 | ±6.8% | -1.5% | over-priced |
| 08/05/2025 | ±9.2% | +1.8% | over-priced |
| 05/06/2025 | ±3.7% | -1.6% | over-priced |
| 11/12/2024 | ±3.7% | -1.1% | over-priced |
| 08/06/2024 | ±2.8% | +6.6% | under-priced |
| 05/02/2024 | ±1.9% | -8.5% | under-priced |
| 11/02/2023 | ±2.0% | +4.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.24 | $3.0B | $126M |
| Q1 FY2026 | $-0.03 | $2.7B | $-15M |
| Q4 FY2025 | $-2.20 | $3.0B | $-1.1B |
| Q3 FY2025 | $-0.09 | $2.8B | $-46M |
Baxter International Inc. (BAX) reports in 116 days, with the next report estimated for 01/02/2027. Across the last 8 reports, options priced an average ±4.2% earnings move while the stock actually moved 4.2% on average — the market has been roughly fair on BAX's earnings risk. Fundamentals into the print: EPS up 33.3% year-over-year, revenue up 5.3%. QuantLogix's live 5-factor engine currently reads BAX as a neutral at 45/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →